• Symbol: MNTR

Mentor Capital, Inc.
  • Home
  • About Us
    • About
    • Professional Support
    • Management Team
    • Board of Directors
  • Media
  • Portfolio & Investments
  • Investors Corner
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Press
  • FAQ
  • Contact
    • Contact Us
    • Funding Application
Mentor Capital, Inc.
  • Home
  • About Us
    • About
    • Professional Support
    • Management Team
    • Board of Directors
  • Media
  • Portfolio & Investments
  • Investors Corner
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Press
  • FAQ
  • Contact
    • Contact Us
    • Funding Application
(800) 574 – 6320
Request a call back
Write us
info@mentorcapital.com
5964 Campus Court
Plano, TX 75093
Home Press

Press

  • Mentor Capital Reports 2014 Revenues of $2.1 Million in 10-K

    • Mar 31, 2015
    gfarmalabs

    First 10-K Filing for Marijuana and Cannabis M&A Leader SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its initial annual 10-K filing for the fiscal year ending December 31, 2014 with the SEC. Mentor CEO, Chet Billingsley, observes, “We voluntarily took this step approximately a year earlier than…

    read more
  • Mentor Capital Shares Accepted for DTC FAST Program for DWAC and DRS Handling

    • Mar 30, 2015
    gfarmalabs

    Cannabis M&A Leader Continues Steps Toward Larger Exchange Listing SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) reports its application to the Depository Trust Company to qualify Mentor shares for accelerated processing through the DTC Fast Automated Securities Transfer system has been approved. Because the DTC is strictly…

    read more
  • Mentor Capital Moves to OTCQB Venture Stage Market Feb 10th

    • Feb 9, 2015
    gfarmalabs

    Cannabis M&A Leader Continues Path Toward Larger Exchange Listing SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTC Pink: MNTR) reports it received confirmation from OTC Markets Group that on February 10, 2015, Mentor Capital will move up to the OTCQB venture stage marketplace for early stage and developing companies under the newly…

    read more
  • Mentor Capital CEO Discusses Marijuana and Ethics in Management Today Magazine

    • Oct 22, 2014
    gfarmalabs

    Ethics Help Businesses to Smoothly Advance Society and in the Cannabis Space are Rapidly Moving Beyond Illegality SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTC Markets: MNTR) is pleased to be on the cover in the “In Defense of Business Ethics” Fall 2014 edition of Management Today. Mentor CEO and article author, Chet Billingsley…

    read more
  • Mentor Capital Announces Second Stock Buyback

    • Aug 8, 2014
    gfarmalabs

    300,000 Shares to be Repurchased with 5% of Cash and Cash-like Assets SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTC Markets: MNTR) is initiating the repurchase of 300,000 shares of its currently outstanding common stock. The repurchase will be funded by the commitment of approximately 5% of the company’s cash and cash-like current assets which are specifically identified and…

    read more
  • Mentor Capital Provides Seed Finance for Nevada Cannabis Fund

    • Jun 3, 2014
    gfarmalabs

    Start-up Cash for Marijuana Focused Fund Provided through Mentor Subsidiary, Nevada Cannabis Ventures SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has provided seed funding to help launch an independently managed cannabis focused fund based in Nevada. The fund anticipates making marijuana related …

    read more
  • Mentor Capital Cancer Immunotherapy Index Up 97% in 2013

    • Jan 21, 2014
    gfarmalabs

    SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 97.4% during 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the same 2013 annual period the biotech…

    read more
  • Mentor Capital Cancer Immunotherapy Index Up 100% in 2013

    • Oct 16, 2013
    gfarmalabs

    SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 101.7% during the first three quarters of 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the same…

    read more
  • Mentor Capital Enters Medical Marijuana Field to Combat Cancer Wasting

    • Sep 30, 2013
    gfarmalabs

    SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has initiated investment in the Medical Marijuana market. “The ‘munchies’ are a godsend to cancer sufferers who just stop eating food that tastes like wood and leaves them nauseous,” explains Mentor CEO, Chester Billingsley. “In the days of clans and caves, elders…

    read more
  • Mentor Capital, Inc. Funds Completion of 12.5% Stock Buyback

    • Sep 5, 2013
    gfarmalabs

    SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCMKTS:MNTR) has deposited funds with its broker to complete the final tranche of its multi-year stock repurchase program. In 2008, Mentor Capital, Inc. committed to the repurchase of 12.5% of its then outstanding common stock and is positioned to wrap-up that stock buy-back now. The purpose of…

    read more
How can we help you?

The best way to contact us is to submit a business inquiry online. Your inquiry will be directed to the appropriate department, and someone will be in touch!

 
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7

    Navigation

    • Home
    • Contact
    • Safe Harbor Statement
    • Privacy Policy
    • Disclaimer
    • Sitemap

    Mentor Capital, Inc

    Mentor Capital, Inc. (MNTR) is a publicly traded operating company that provides owners and pre-IPO companies with access to liquidity and funding from both public sources and the divestiture of legacy assets.

    Subscribe

    Recent News

    • Mentor Capital Posts 40% Annual Revenue Gain in 10-Q May 16, 2022
    • Mentor Capital Reports 2021 Revenues of 26 cents per Share Mar 28, 2022
    • Mentor Capital Revenues Up 21.2% for the 3rd Quarter 2021 Nov 15, 2021
    Copyright © 2022 Mentor Capital, Inc. All rights reserved.